ECC 2015 | Molecular drivers of metastatic disease in breast cancer

Giuseppe Curigliano

At the European Cancer Congress (ECC) 2015, Giuseppe Curigliano, MD, PhD, from Istituto Europeo di Oncologia, Milan, Italy, explains that genetic differences between primary and metastatic breast cancer may have important clinical implications, including for the identification of biomarkers in disease progression.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter